Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55,351,475
-
Total 13F shares
-
42,483,912
-
Share change
-
-1,058,818
-
Total reported value
-
$161,435,866
-
Price per share
-
$3.80
-
Number of holders
-
43
-
Value change
-
-$5,643,294
-
Number of buys
-
21
-
Number of sells
-
34
Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q2 2022
As of 30 Jun 2022,
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,483,912 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, HarbourVest Partners LLC, Artal Group S.A., STATE OF WISCONSIN INVESTMENT BOARD, CHI Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., PLATINUM INVESTMENT MANAGEMENT LTD, and Laurion Capital Management LP.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.